FDA Taps Simcyp to Develop Dog Simulator for Veterinary Medicine | GenomeWeb

Simcyp, a division of Certara, said this week that it has entered into a Cooperative Research and Development Agreement with the US Food and Drug Administration to further develop the Simcyp Dog model for the evaluation of drug products intended for use in different canine breeds.

Over the next five years, Simcyp and researchers at the FDA's Center for Veterinary Medicine will develop physiologically based pharmacokinetic dog models that will help streamline the process of veterinary drug product development and evaluation.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In PLOS this week: cell-free DNA from tumors is shorter than DNA from healthy cells, type 2 diabetes-related loci, and more.

Genetic analysis confirms that blood found on leaves collected near Marche-les-Dames some 80 years ago belongs to King Albert I of Belgium.

Researchers in the US begin to seek participants for the 1 million-person precision medicine cohort, the New York Times reports.

A new report indicates that women are underrepresented among US patent holders.